S. Kaptein

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Suzanne J F Kaptein, Suzanne F Kaptein, Suzanne Kaptein, S. Kaptein, Suzanne J. F. Kaptein, Suzanne J.f. Kaptein
Publication record
45 papers · 2,770 citations · H-index 16

PAPERS

Oropouche virus results in severe congenital disease in embryonic mice
20251 citationsauthor #7
Discovery of orally bioavailable Zika and West Nile Virus antiviral compounds targeting the NS2B-NS3 protease
20251 citationsauthor #15
Hepatitis E Virus Infection in Vietnamese Pregnant Women with Hepatitis B: Prevalence and Clinical Outcomes
20253 citationsauthor #47
Proliferative Cell Targeting and Epithelial Cell Turnover Fuels Hepatitis E Virus Replication in Human Intestinal Enteroids
20252 citationsauthor #9
New spirooxindole-benzothiazole hybrids incorporating a trifluoromethyl moiety as antiviral agents: Design, synthesis, crystal structure analysis, and in silico studies
20250 citationsauthor #3
A pan-genotypic hepatitis E virus replication inhibitor with high potency in a rat infection model.
20244 citationsauthor #17
The tyrosine kinase Yes1 is a druggable host factor of HEV
20245 citationsauthor #10
Discovery of JNJ-1802, a First-in-Class Pan-Serotype Dengue Virus NS4B Inhibitor.
202415 citationsauthor #6
The antiviral JNJ-A07 significantly reduces dengue virus transmission by Aedes aegypti mosquitoes when delivered via blood-feeding
20242 citationsauthor #9
Pan-serotype dengue virus inhibitor JNJ-A07 targets NS4A-2K-NS4B interaction with NS2B/NS3 and blocks replication organelle formation
202421 citationsauthor #9
Multiplexed multicolor antiviral assay amenable for high-throughput research
20248 citationsauthor #12
Epidemic Zika virus strains from the Asian lineage induce an attenuated fetal brain pathogenicity
20248 citationsauthor #11
Blocking NS3–NS4B interaction inhibits dengue virus in non-human primates
202382 citationsauthor #2
Discovery of Acyl-Indole Derivatives as Pan-Serotype Dengue Virus NS4B Inhibitors.
20238 citationsauthor #6
Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitro
202348 citationsauthor #5
Author Correction: Reverse engineering synthetic antiviral amyloids
20230 citationsauthor #13
Establishment of a robust rat hepatitis E virus fecal-oral infection model and validation for antiviral studies.
20239 citationsauthor #8
Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches
2022684 citationsauthor #23
A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection
202212 citationsauthor #3
inhibits SARS-CoV-2 replication and enhances the efficacy of favipiravir in 1 a Syrian hamster infection model 2
20210 citationsauthor #3
Use of Micro-Computed Tomography to Visualize and Quantify COVID-19 Vaccine Efficiency in Free-Breathing Hamsters.
20217 citationsauthor #3
A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction
2021150 citationsauthor #1
Spatial proteogenomics reveals distinct and evolutionarily-conserved hepatic macrophage niches
20211 citationsauthor #22
The legacy of ZikaPLAN: a transnational research consortium addressing Zika
20219 citationsauthor #19
Alphavirus and flavivirus infectivity is disrupted by components of the bacterial cell wall
20210 citationsauthor #5
Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters
2021105 citationsauthor #9
Comparative infectivity and pathogenesis of emerging SARS-CoV-2 variants in Syrian hamsters
202122 citationsauthor #9
Publisher Correction: A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction
20214 citationsauthor #1
The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model
2021115 citationsauthor #3
Perturbation of Alphavirus and Flavivirus Infectivity by Components of the Bacterial Cell Wall
20216 citationsauthor #5
An affinity-enhanced, broadly neutralizing heavy chain–only antibody protects against SARS-CoV-2 infection in animal models
202156 citationsauthor #43
Publisher Correction: A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction
20210 citationsauthor #1
Corrigendum to “itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens”
20211 citationsauthor #34
Nelfinavir markedly improves lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect
20217 citationsauthor #3
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
2020228 citationsauthor #3
The combined treatment of Molnupiravir and Favipiravir results in a marked potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model
202016 citationsauthor #3
Animal models for COVID-19
2020797 citationsauthor #29
Small-molecule inhibitors of TBK1 serve as an adjuvant for a plasmid-launched live-attenuated yellow fever vaccine
202010 citationsauthor #5
High transmissibility and fetal pathogenicity of recent Zika virus strains from the African lineage
20202 citationsauthor #25
Itraconazole for COVID-19: Preclinical Studies and a Proof-of-Concept Pilot Clinical Study
20203 citationsauthor #30
Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients
202052 citationsauthor #9
STAT2 signaling as double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-2 infected hamsters
202048 citationsauthor #3
A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate
2020175 citationsauthor #11
A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice
201851 citationsauthor #10
Late Breaker Oral Presentation Sessions
20170 citationsauthor #5

TIMELINE

2017 0 citations

2018 51 citations

2020 1,331 citations

2021 483 citations

2022 696 citations

2023 147 citations

2024 63 citations

2025 7 citations

S. Kaptein

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT